2020
DOI: 10.2139/ssrn.3552628
|View full text |Cite
|
Sign up to set email alerts
|

Plasminogen Improves Lung Lesions and Hypoxemia in Patients with COVID-19

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 20 publications
0
4
0
Order By: Relevance
“…Six patients with severe infection had improvement in oxygen saturation, five patients with moderate infection had radiological improvement of pneumonia, and two critical patients with hypoxemia had improvement in saturation within an hour. [10] The limitations of this study are the small sample size, nonrandomized design, and mortality not being evaluated as an endpoint.…”
Section: Hydroxychloroquine/chloroquine and Azithromycinmentioning
confidence: 97%
See 1 more Smart Citation
“…Six patients with severe infection had improvement in oxygen saturation, five patients with moderate infection had radiological improvement of pneumonia, and two critical patients with hypoxemia had improvement in saturation within an hour. [10] The limitations of this study are the small sample size, nonrandomized design, and mortality not being evaluated as an endpoint.…”
Section: Hydroxychloroquine/chloroquine and Azithromycinmentioning
confidence: 97%
“…Plasminogen is a key regulator in fibrin degradation, wound healing, and infection. [10] A study from China with 13 patients who had moderate-tosevere COVID-19 infection were treated with atomization inhalation of free-dried plasminogen (10 mg OD for moderate and 10 mg BD for severe infection). Six patients with severe infection had improvement in oxygen saturation, five patients with moderate infection had radiological improvement of pneumonia, and two critical patients with hypoxemia had improvement in saturation within an hour.…”
Section: Hydroxychloroquine/chloroquine and Azithromycinmentioning
confidence: 99%
“…ARDS patients have been shown increased levels of plasminogen. Studies suggest that during COVID-19 infections supplementary plasminogen may be effective in handling lung lesions and hypoxemia [29].…”
Section: Treatment Of Hypoxemia In Covid-19mentioning
confidence: 99%
“…An indirect harm to the heart may also occur by hypoxemia caused by COVID-19 infection. There are pieces of evidence to prove that hypoxia plays a significant role in the cardiovascular risk development [63,64]. Moreover, COVID-19 patients represent low levels of lymphocyte, albumin, potassium, and eosinophil [65].…”
Section: Cardiovascular Systemmentioning
confidence: 99%